Government of Germany   Report issue

Government Phase 1 Phase 2 Phase 4

Organization Overview

First Clinical Trial
2002
NCT00167843
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Bayerisches Staatsministerium für Wirtschaft und Medien, Energie und Tehchnologie | Bundesministerium fuer Bildung und Forschung (BMBF) | Federal Agency for Disruptive Innovation - SPRIN-D | Federal Institute for Occupational Safety and Health (BAuA)/Germany) | German Centre for Assessment and Evaluation of Innovative Techniques in Medicine | Innovation Fund of the Joint Federal Committee (Gemeinsamer Bundesausschuss, G-BA), Germany | Ministry of Innovation, Science and Research in North Rhine-Westphalia | The Federal Ministry of Health, Germany (Bundesministerium für Gesundheit, BMG)